GLUXIT S 10/100 TAB
Eris Lifesciences Ltd.
Product Information
Description
GLUXIT S 10/100 Tablet, manufactured by Eris Lifesciences Ltd, is an oral anti-diabetic combination medication containing Dapagliflozin (10mg) and Sitagliptin (100mg). It is designed to manage Type 2 diabetes mellitus in adults by improving blood sugar control, usually when other treatments like metformin are insufficient. Mechanism: Dapagliflozin increases glucose excretion in the urine, while Sitagliptin improves insulin levels and reduces sugar production by the liver.
Administration: It is typically taken once daily with or without food as prescribed by a physician.
Precautions: Not recommended for patients with severe kidney disease or those on dialysis. Inform a doctor if you have liver problems, heart issues, or are prone to urinary tract infections.
Side Effects: Common side effects include hypoglycemia (low blood sugar), nausea, dizziness, urinary tract infections, and headache.